A Bioequivalence Study of Serum Free Avonex and Serum Containing Avonex in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2003

Study Completion Date

October 31, 2003

Conditions

Multiple Sclerosis

Interventions

DRUG

Serum containing Avonex

60mcg IM dose of serum containing Avonex on Day 1, followed by 60mcg IM dose of serum free Avonex on Day 15

DRUG

Serum Free Avonex

60mcg IM dose of serum free Avonex on Day 1, followed by 60mcg IM dose of serum containing Avonex on Day 15.